Table 2.
N (Range/%) | |
---|---|
Patients, n | 81 |
Sex | |
Male | 39 |
Female | 42 |
Mean age, years | 68.3 (31–92) |
BMI, Ø | 28.6 (19.1–4.2) |
ASA grade, n (%) | |
I | 1 (1.2) |
II | 54 (66.7) |
III | 25 (30.9) |
IV | 1 (1.2) |
Smoker status, n (%) | |
Smoker | 16 (19.8) |
Non-smoker | 65 (80.2) |
Type II diabetes, n (%) | |
Yes | 18 (22.2) |
No | 63 (77.8) |
Diagnosis, n (%) | |
Benign | 42 (51.9) |
Malignant | 39 (48.1) |
Surgical technique, n (%) | |
Laparoscopic | 39 (48.1) |
Open | 42 (51.9) |
Surgical procedure, n (%) | |
Hernioplasty | 21 (25.9) |
Right hemicolectomy | 17 (21.0) |
Sigmoidectomy | 14 (17.3) |
Rectum resection | 6 (7.4) |
Rectosigmoidectomy | 5 (6.2) |
Left hemicolectomy | 5 (6.2) |
Ileostomy reversal | 5 (6.2) |
Hartmann reversal procedure | 2 (2.4) |
Liver resection | 1 (1.2) |
Resection of transverse colon | 1 (1.2) |
Subtotal colectomy | 1 (1.2) |
Gastrectomy | 1 (1.2) |
Reversal of a loop colostomy | 1 (1.2) |
Open cholecystectomy | 1 (1.2) |
Contamination class, n (%) | |
Class I (clean) | 20 (24.7) |
Class II (clean-contaminated) | 8 (9.9) |
Class III (contaminated) | 53 (65.4) |
Wound length, Ø cm | 12.8 |
Post-op lenght of stay (Ø days) | 8.4 (2–28 d) |
Clavien-Dindo classification, n (%) | |
Grade 2/Group I | 8 (9.9) |
Grade 3a/Group II | 8 (9.9) |
Grade 4/Group III | 1 (1.2) |
SSI according CDC criteria | |
Study stage I + II | 3 CDC grade 1 (superficial) |
Study stage I | 0 |
Study stage II | 3 CDC grade 1 (superficial) |
BMI, body mass index, ASA, American Society of Anaesthesiologists, CDC, Centre for Disease Control and Prevention/USA; SSIs, surgical site infection.